CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Shares withheld for taxes Interim CFO gave up 1,297 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,161 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chairman & CEO sold 251,572 shares at an average $21.02 ($5,288,013)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP & Chief Legal Officer sold 29,589 shares at an average $25.37 ($750,678)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP & Chief Legal Officer sold 13,752 shares at $25.07 ($344,763)
Page 16 of 20 · 386 filings